Telesis Bio Inc Revenue
What is the Revenue of Telesis Bio Inc?
The Revenue of Telesis Bio Inc is $17.531M
What is the definition of Revenue?
Revenue is the income that a business has from its normal business activities, usually from the sale of goods and services to customers.
ttm (trailing twelve months)
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Revenue of companies in the Health Care sector on NASDAQ compared to Telesis Bio Inc
What does Telesis Bio Inc do?
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
Companies with revenue similar to Telesis Bio Inc
- Kiadis Pharma N.V has Revenue of €17.500M
- Kiadis Pharma NV has Revenue of €17.500M
- Timeless Software has Revenue of HKD$17.506M
- Patagonia Gold has Revenue of $17.516M
- Henderson High Income Trust has Revenue of £17.520M
- i2S SA has Revenue of €17.520M
- Telesis Bio Inc has Revenue of $17.531M
- Sofibus Patrimoine S.A has Revenue of €17.539M
- BNK Banking has Revenue of AUD$17.560M
- Datasea has Revenue of $17.574M
- Datasea has Revenue of $17.574M
- Datasea has Revenue of $17.574M
- Datasea has Revenue of $17.574M